MBA Klaus Müller MD

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
In the article “Re-irradiation with cetuximab or cisplatinbased chemotherapy for recurrent squamous cell carcinoma of the head and neck” Dornoff et al. suggested a new prognostic score for the survival of relapsed head and neck cancer patients after salvage treatment consisting of re-irradiation with concurrent immunoor chemotherapy. Ranging from 0 to 4(More)
  • 1